BioCryst Pharmaceuticals (BCRX) Stock: Why It Surged 23.23%

By Pulse 2.0 Staff ● Aug 5, 2022
  • The stock price of BioCryst Pharmaceuticals (BCRX) surged by 23.23% in the previous trading session. This is why.

The stock price of BioCryst Pharmaceuticals (BCRX) surged by 23.23% in the previous trading session. 

BioCryst had reported a Q2 EPS of ($0.32), which was $0.02 higher than analyst estimates of ($0.34). And the revenue for the quarter was $65.2 million compared to the consensus estimate of $63.33 million.